3 Single Use Medical Device Maker, Precision Plastic Components Specialist and Houseware Brand Stocks With a Strong Future Roadmap: Poly Medicure, Shaily Engineering Plastics and Cello World

Poly Medicure, Shaily Engineering Plastics and Cello World: ROE of 10.4% to 23.7% and FY22 to FY26 revenue CAGR of 14.7% to 20.0%. Prices as of 28 Oct 2026.

Updated: 29 Oct 2026 • 12:47 pm

Posted by:

Quick Answer

The three medical device and moulded products stocks to watch are Poly Medicure, Shaily Engineering Plastics and Cello World. Their return on equity ranges from 10.4% to 23.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.7% to 20.0%. Shaily Engineering Plastics has the highest return on equity at 23.7%, while Poly Medicure has the fastest revenue growth at 20.0% a year. Prices are based on the 28 October 2026 close, and this article is educational, not investment advice.

Medical device and moulded products stocks let investors follow companies that serve a growing part of the Indian economy. Poly Medicure, Shaily Engineering Plastics and Cello World cover a single use medical device maker, a precision plastic components specialist and a houseware brand.

This list covers three medical device and moulded products stocks with complete current figures: Poly Medicure, Shaily Engineering Plastics and Cello World. Every figure comes from the latest reported financials and the 28 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

What Are Medical Device and Moulded Products Stocks?

Medical device and moulded products stocks are listed companies that make infusion sets, syringes and catheters, produce moulded plastic parts for drug delivery devices and automobiles, and sell houseware, writing instruments and glassware to families. Their earnings depend on volumes, product mix and export orders.

Medical Device and Moulded Products Stocks at a Glance

Company	CMP (Rs)	Market Cap (Rs Cr)	P/E	Industry P/E	ROE (%)	D/E
Poly Medicure	1,476	15,721	50.2	59.6	10.4	0.11
Shaily Engineering Plastics	3,048.7	13,693	77.5	35.6	23.7	0.25
Cello World	333.2	7,985	24.6	41.4	12.3	0.01

On valuation, Poly Medicure and Cello World trade at a P/E below the industry P/E, while Shaily Engineering Plastics trades above it, which reflects the growth the market already expects. Readers comparing medical device and moulded products stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Medical Device and Moulded Products Stocks Have a Strong Roadmap in India?

Medical device and moulded products stocks have a strong roadmap in India because rising hospital use of disposable devices, global outsourcing of precision moulding and growing household spending keep widening the market for these device and plastics companies.

Disposable devices. Hospitals use single use products every day.
Global customers. Overseas orders support volumes.
Brand reach. A wide retail network supports household sales.

Why Poly Medicure Features Among These Medical Device and Moulded Products Stocks

Among the medical device and moulded products stocks on this list, Poly Medicure makes single-use medical devices such as infusion sets, syringes, catheters, blood management products and dialysis consumables, and it exports to many countries.

In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%.

Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6.

Roadmap: The company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.

What to watch: Track export growth, new product approvals and plant capacity use.

Why Shaily Engineering Plastics Features Among These Medical Device and Moulded Products Stocks

Among the healthcare consumables and plastics shares on this list, Shaily Engineering Plastics makes precision injection moulded plastic components, including parts for medical drug-delivery devices, consumer products and automobiles, mainly for global customers.

The company has a return on equity of 23.7%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 13,693 crore. The stock trades at a P/E of 77.5, above the industry P/E of 35.6.

Revenue rose from Rs 577 crore in FY22 to Rs 998 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 35.3 crore in FY22 to Rs 170 crore in FY26, which works out to a compound annual growth rate of 48.2%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 281 crore, while net profit rose 16.8% to Rs 48.0 crore.

Roadmap: The company is expanding in healthcare and consumer components, where global brands outsource complex moulding to trusted makers. Added capacity and new customer programmes support its order flow.

What to watch: Watch new customer programmes in drug-delivery devices and the pace of capacity additions.

Why Cello World Features Among These Medical Device and Moulded Products Stocks

Among the three companies on this list, Cello World is a consumer products company that sells houseware, writing instruments, glassware and moulded furniture under the Cello brand through a wide distribution network.

Revenue rose from Rs 1,375 crore in FY22 to Rs 2,379 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 220 crore in FY22 to Rs 332 crore in FY26, which works out to a compound annual growth rate of 10.9%.

The company has a return on equity of 12.3%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 7,985 crore. The stock trades at a P/E of 24.6, below the industry P/E of 41.4.

Roadmap: The company is growing its glassware and houseware ranges and expanding its reach in modern retail. A trusted household brand helps it enter new product categories.

What to watch: Track growth in glassware and writing instruments, distribution expansion and input costs.

Poly Medicure vs Shaily Engineering Plastics vs Cello World on Key Financials

The table below sets the three medical device and moulded products stocks side by side on revenue, profit and margin, using reported figures.

Company	FY22 Revenue (Rs Cr)	FY26 Revenue (Rs Cr)	Revenue CAGR (FY22-FY26)	FY26 Net Profit (Rs Cr)	FY26 Net Margin
Poly Medicure	961	1,995	20.0%	321	16.1%
Shaily Engineering Plastics	577	998	14.7%	170	17.0%
Cello World	1,375	2,379	14.7%	332	13.9%

Shaily Engineering Plastics posts the highest return on equity in this group at 23.7%. Cello World has the largest FY26 revenue at Rs 2,379 crore, and Poly Medicure shows the fastest revenue growth with a 20.0% compound annual rate. A useful habit with medical device and moulded products stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Medical Device and Moulded Products Stocks

Every theme carries risks that deserve a check before any decision. For these medical device and moulded products stocks, the main points are: Long-term healthcare consumables and plastics shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

Medical device rules. Approvals and quality standards can affect launches.
Raw material costs. Ingredient and packaging prices can move margins.
Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter medical device and moulded products stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Medical Device and Moulded Products Stocks

Medical device and moulded products stocks reward investors who follow demand trends, order books and margins together. Poly Medicure, Shaily Engineering Plastics and Cello World each have a clear plan to grow. Based on the 28 October 2026 close, Poly Medicure trades at Rs 1,476, Shaily Engineering Plastics at Rs 3,048.7 and Cello World at Rs 333.2.

Download the Univest iOS App or Univest Android App to track medical device and moulded products stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are medical device and moulded products stocks?

Ans. Medical device and moulded products stocks are listed companies that make infusion sets, syringes and catheters, produce moulded plastic parts for drug delivery devices and automobiles, and sell houseware, writing instruments and glassware to families. Their earnings depend on volumes, product mix and export orders. This list looks at three of them, Poly Medicure, Shaily Engineering Plastics and Cello World, using reported FY22 to FY26 financials and the 28 October 2026 closing prices.

Which medical device and moulded products stocks are covered in this list?

Ans. This list covers Poly Medicure, Shaily Engineering Plastics and Cello World. Based on the 28 October 2026 close, Poly Medicure traded at Rs 1,476, Shaily Engineering Plastics at Rs 3,048.7 and Cello World at Rs 333.2. Their return on equity ranges from 10.4% to 23.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.7% to 20.0%.

Why do medical device and moulded products stocks have a strong future roadmap in India?

Ans. Medical device and moulded products stocks have a strong roadmap in India because rising hospital use of disposable devices, global outsourcing of precision moulding and growing household spending keep widening the market for these device and plastics companies. The main drivers are as follows. Disposable devices. Hospitals use single use products every day. Global customers. Overseas orders support volumes. Brand reach. A wide retail network supports household sales. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Poly Medicure performed financially?

Ans. Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%. Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%. In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6. Looking ahead, the company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.

How has Shaily Engineering Plastics performed financially?

Ans. Revenue rose from Rs 577 crore in FY22 to Rs 998 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 35.3 crore in FY22 to Rs 170 crore in FY26, which works out to a compound annual growth rate of 48.2%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 281 crore, while net profit rose 16.8% to Rs 48.0 crore. The company has a return on equity of 23.7%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 13,693 crore. The stock trades at a P/E of 77.5, above the industry P/E of 35.6. Looking ahead, the company is expanding in healthcare and consumer components, where global brands outsource complex moulding to trusted makers. Added capacity and new customer programmes support its order flow.

How has Cello World performed financially?

Ans. Revenue rose from Rs 1,375 crore in FY22 to Rs 2,379 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 220 crore in FY22 to Rs 332 crore in FY26, which works out to a compound annual growth rate of 10.9%. The company has a return on equity of 12.3%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 7,985 crore. The stock trades at a P/E of 24.6, below the industry P/E of 41.4. Looking ahead, the company is growing its glassware and houseware ranges and expanding its reach in modern retail. A trusted household brand helps it enter new product categories.

What risks should investors check before buying medical device and moulded products stocks?

Ans. Investors should check a few risks before buying medical device and moulded products stocks. Medical device rules. Approvals and quality standards can affect launches. Raw material costs. Ingredient and packaging prices can move margins. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of medical device and moulded products stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 28 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.